EUVIMEDEUVIMED entdecken
Open Access

The Effect of Artemisinin on the Pharmacokinetics of Cyclophosphamide and Its Metabolite in Mice and Its Potential Mechanisms

Huilong Wang, Wenting Zhang, Haifeng Hu, Shaozhen Wang, Yuewu Xie iD

Biomedical Chromatography · 2026-09 · 40 (9)

DOI: 10.1002/bmc.70589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 06.08.2026. Verfasst von Huilong Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Wannan Medical University, Wuhu, China. Hauptthemen laut MEDLINE: Artemisinins, Cyclophosphamide. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Program for Excellent Sci-Tech Innovation Teams of Universities in Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclophosphamide (CP) is a common alkylating anticancer drug. Artemisinin (ART), an antimalarial agent metabolized by hepatic CYP450s, exhibits promising antitumor activity. This study established a rapid and accurate LC‐MS/MS method for the quantitative analysis of CP and its metabolite in mouse plasma, as well as to apply this method in assessing how ART influences the pharmacokinetics of CP. Given the instability of 4‐OH‐CP, 4‐keto‐CP was selected as a surrogate metabolite for detection. The effect of ART on the mRNA expression and activity of CYP450 enzymes were assessed by RT‐qPCR and substrate cocktail assay. The results indicated that CP and 4‐keto‐CP were linear in the range of 1–2000 and 2–2000 ng/mL, respectively. The accuracy, precision, extraction recovery, stability, and matrix effect of CP and 4‐keto‐CP are complied with the Bioanalytical Method Validation Guidelines. ART significantly reduced the AUC 0− t of CP by 26.6%, while increasing CL/F by 1.35‐fold. Concurrently, the AUC 0− t and C max of 4‐keto‐CP increased by 1.42‐ and 1.45‐fold, respectively. Furthermore, ART can markedly upregulate the mRNA expression and activity of CAR/ CYP2B6 . The results showed that pretreatment with ART could induce CP metabolism to its active metabolite. This study provides implications for the rational use of the ART‐CP combination in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsCyclophosphamideAnimalsMiceTandem Mass SpectrometryReproducibility of ResultsMaleLinear ModelsLiquid Chromatography-Mass SpectrometryLimit of DetectionCytochrome P-450 Enzyme System

Stichwörter der Autor:innen

LC‐MS/MSartemisinincyclophosphamidedrug interactionpharmacokinetics

Substanzen

ArtemisininsCyclophosphamideartemisininCytochrome P-450 Enzyme System

Autor:innen und Institutionen

  • School of Pharmacy, Wannan Medical University, Wuhu, China.

ORCID-Profile: Yuewu Xie

Förderung

  • National Natural Science Foundation of China
  • Program for Excellent Sci-Tech Innovation Teams of Universities in Anhui Province

Zitieren

APA

Wang, H., Zhang, W., Hu, H., Wang, S., & Xie, Y. (2026). The Effect of Artemisinin on the Pharmacokinetics of Cyclophosphamide and Its Metabolite in Mice and Its Potential Mechanisms. Biomedical Chromatography, 40(9). https://doi.org/10.1002/bmc.70589

Vancouver

Wang H, Zhang W, Hu H, Wang S, Xie Y. The Effect of Artemisinin on the Pharmacokinetics of Cyclophosphamide and Its Metabolite in Mice and Its Potential Mechanisms. Biomedical Chromatography. 2026;40(9). doi:10.1002/bmc.70589

BibTeX
@article{Wang2026,
  author = {Wang, Huilong and Zhang, Wenting and Hu, Haifeng and Wang, Shaozhen and Xie, Yuewu},
  title = {The Effect of Artemisinin on the Pharmacokinetics of Cyclophosphamide and Its Metabolite in Mice and Its Potential Mechanisms},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {9},
  doi = {10.1002/bmc.70589}
}
Kostenlos starten →